Please use this identifier to cite or link to this item:
https://scholars.lib.ntu.edu.tw/handle/123456789/583631
Title:
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study